The US FDA just authorised the Pfizer booster dose for 5-11 year-old kids!
Here is what you need to know…
US FDA Approves Pfizer Booster Dose For 5-11 Yo Kids!
On 17 May 2022, the US Food and Drug Administration (US FDA) authorised the use of a single booster dose of the Pfizer-BioNTech COVID-19 vaccine for 5-11 year old kids.
This booster dose is to be given at least 5 months after the primary series of two doses is given.
This follows the US FDA approval of a booster dose of the Pfizer-BioNTech COVID-19 vaccine for 12-15 year old kids on 3 January 2022.
FDA Commissioner Robert M. Califf, M.D. said :
Why US FDA Approved Pfizer Booster Dose For 5-11 Yo Kids
The US FDA approved the Pfizer booster dose for 5-11 year-old kids based on their analysis of the immune response data in a subset of children from the ongoing randomised placebo-controlled trial that supported the earlier October 2021 approval of the vaccine for this age group.
Increased Antibody Levels
The antibody response of 67 study participants who received the booster dose 7-9 months after completing their primary series vaccination, were evaluated, and found to increase antibody levels one month after receiving the booster dose.
The US FDA also assessed the safety of the booster dose in approximately 400 children who received the booster dose 5-9 months after completing their primary series vaccination.
The most commonly reported side effects were pain, redness and swelling at the injection site, fatigue, headache, muscle or joint pain, and chills and fever.
Peter Marks, M.D., Ph.D., director of the FDA’s Center for Biologics Evaluation and Research, said :
- How I Managed To Walk In To Renew My Passport!
- Did Italian Court Rule Vaccine Mandate As Unconstitutional?!
- Fact Check : Did Lil Keed Die From Pfizer COVID-19 Vaccine?!
- Did Clever Putin Force EU Countries To Buy Gas In Rubles?!
- How Did Ukrainian Windows Stay Intact After Explosion?!
If you like our work, please support us by visiting our sponsors, or donating to our fund. Thank you!